SCHEMBL8790759

SCHEMBL8790759

COc1cc(OC)c2[nH]c3c(C(=O)O)cccc3c(=O)c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 2/20 0.52
KDM4E B2RXH2 6/20 0.51
ALDH1A1 P00352 3/20 0.51
HPGD P15428 3/20 0.51
STING1 Q86WV6 1/20 0.48
POLB P06746 3/20 0.48
MAPT P10636 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
MCL1 Q07820 2/20 0.48
LMNA P02545 1/20 0.48
BLM P54132 1/20 0.48
NQO2 P16083 1/20 0.46
GAA P10253 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
TSHR P16473 1/20 0.45
HTT P42858 1/20 0.45
RECQL P46063 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ABCG2 Q9UNQ0 5/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8790775 0.87 KDM4E (0.66) PBRM1KDM4EALDH1A1HPGDSTING1
SCHEMBL31738495 0.87 KDM4E (0.66) PBRM1KDM4EALDH1A1HPGDSTING1
SCHEMBL8132211 0.86 PBRM1 (0.52) PBRM1KDM4EALDH1A1HPGDSTING1
SCHEMBL8789976 0.81 PBRM1 (0.64) PBRM1KDM4EALDH1A1HPGDSTING1
SCHEMBL11741686 0.80 KDM4E (0.63) PBRM1KDM4EALDH1A1HPGDPOLB
SCHEMBL8789725 0.78 KDM4E (0.58) PBRM1KDM4EALDH1A1HPGDSTING1
SCHEMBL23061231 0.75 STING1 (0.60) PBRM1KDM4EALDH1A1HPGDSTING1
SCHEMBL30353206 0.75 KDM4E (0.64) KDM4EALDH1A1HPGDPOLBMEN1
SCHEMBL9550632 0.75 KDM4E (0.65) PBRM1KDM4EALDH1A1HPGDSTING1
SCHEMBL30083760 0.75 KDM4E (0.65) PBRM1KDM4EALDH1A1HPGDSTING1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0569380-B1 ACRIDINE DERIVATIVES GLAXO LAB SA (FR) 1997-05-28 EP disclosed
US-5604237-A IMPROVE OR INCREASE EFFICACY OF ANTITUMOR AGENT, INCREASE OR RESTORE SENSITIVITY OF TUMOR TO ANTITUMOR AGENT, REVERSE OR REDUCE RESISTANCE OF TUMOR TO ANTITUMOR AGENT LABORATOIRES GLAXO SA (FR) 1997-02-18 US disclosed
EP-0569380-A1 ACRIDINE DERIVATIVES. GLAXO LAB SA (FR) 1993-11-18 EP disclosed
WO-1992012132-A1 ACRIDINE DERIVATIVES LABORATOIRES GLAXO S.A. (FR) 1992-07-23 WO disclosed
EP-0494623-A1 Acridine derivatives LABORATOIRES GLAXO SA (FR) 1992-07-15 EP disclosed